Anatabine ameliorates experimental autoimmune thyroiditis

Endocrinology

Volumn 153, Issue 9, 2012, Pages 4580-4587

  Caturegli, Patrizio ^a,b   De Remigis, Alessandra ^a   Ferlito, Marcella ^a   Landek Salgado, Melissa A ^a   Iwama, Shintaro ^a   Tzou, Shey Cherng ^a   Ladenson, Paul W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; ANATABINE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 18; THYROGLOBULIN ANTIBODY; THYROXINE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNIZATION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID FUNCTION;

ALKALOIDS; ANIMALS; CELL LINE; FEMALE; MICE; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROIDITIS, AUTOIMMUNE;

EID: 84865411321     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1452     Document Type: Article

References (30)

1. Belin RM, Astor BC, Powe NR, Ladenson PW 2004 Smoke exposure is associated with a lower prevalence of serum thyroid auto-antibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 89:6077-6086
2. Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM 2003 Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:396-401
3. Pedersen IB, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Rasmussen LB 2008 Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: a population study. Eur J Endocrinol 158:367-373
4. Effraimidis G, Tijssen JG, Wiersinga WM 2009 Discontinuation of smoking increases the risk for developing thyroid peroxidase anti-bodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab 94:1324-1328
5. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS 1988 Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 23:1147-1152
6. Fraga XF, Vergara M, Medina C, Casellas F, Bermejo B, Malagelada JR 1997 Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol 9:683-687
7. Mokbel M, Carbonnel F, Beaugerie L, Gendre JP, Cosnes J 1998 [Effect of smoking on the long-term course of ulcerative colitis]. Gastroenterol Clin Biol 22:858-862
8. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB 2012 Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis 6:756-762
9. Sopori M 2002 Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372-377
10. Tracey KJ 2007 Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289-296
11. Miwa JM, Freedman R, Lester HA 2011 Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 70:20-33
12. Gahring LC, Rogers SW 2005 Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J 7:E885-E894
13. Bencherif M, Lippiello PM, Lucas R, Marrero MB 2011 α7 Nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 68:931-949
14. Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T 2009 Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183:6681-6688
15. Paris D, Beaulieu-Abdelahad D, Bachmeier C, Reed J, Ait-Ghezala G, Bishop A, Chao J, Mathura V, Crawford F, Mullan M 2011 Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. Eur J Pharmacol 670:384-391
16. Kimura H, Kimura M, Tzou SC, Chen YC, Suzuki K, Rose NR, Caturegli P 2005 Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization. Endocrinology 146:1154-1162
17. Landek-Salgado MA, Tzou SC, Kimura H, Caturegli P 2010 Induction of experimental autoimmune hypophysitis in SJL mice. J Vis Exp pii 2182
18. Reagan-Shaw S, Nihal M, Ahmad N 2008 Dose translation from animal to human studies revisited. FASEB J 22:659-661
19. Kimura H, Kimura M, Westra WH, Rose NR, Caturegli P 2005 Increased thyroidal fat and goitrous hypothyroidism induced by interferon-γ. Int J Exp Pathol 86:97-106
20. Rocchi R, Kimura H, Tzou SC, Suzuki K, Rose NR, Pinchera A, Ladenson PW, Caturegli P 2007 Toll-like receptor-MyD88 and Fc receptor pathways of mast cells mediate the thyroid dysfunctions observed during nonthyroidal illness. Proc Natl Acad Sci USA 104:6019-6024
21. Allen EM, Hsueh WC, Sabra MM, Pollin TI, Ladenson PW, Silver KD, Mitchell BD, Shuldiner AR 2003 A genome-wide scan for autoimmune thyroiditis in the Old Order Amish: replication of genetic linkage on chromosome 5q11.2-q14.3. J Clin Endocrinol Metab 88:1292-1296
22. Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR 2011 Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab 96:E1466-E1471
23. Masters SL, Simon A, Aksentijevich I, Kastner DL 2009 Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621-668
24. Rosas-Ballina M, Tracey KJ 2009 Cholinergic control of inflammation. J Intern Med 265:663-679
25. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Wang H, Metz C, Miller EJ, Tracey KJ, Ulloa L 2004 Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216-1221
26. Smith DE 2011 The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol 89:383-392
27. Takiyama Y, Miyokawa N, Tokusashi Y, Ito K, Kato S, Kimura S, Sato K, Katagiri M 2002 Thyroid-stimulating hormone induces interleukin-18 gene expression in FRTL-5 cells: immunohistochemical detection of interleukin-18 in autoimmune thyroid disease. Thyroid 12:935-943
28. Liu Z, Wang H, Xiao W, Wang C, Liu G, Hong T 2010 Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis. Int J Exp Pathol 91:420-425
29. Gabay C, Lamacchia C, Palmer G 2010 IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6:232-241
30. Iwama S, De Remigis A, Bishop A, Kimura H, Caturegli P 2012 Hürthle cells predict hypothyroidism in interferon-γ transgenic mice of different genetic backgrounds. Endocrinology 153:4059-4066